Downloads
-
Analysis Of Drug-Excipient Incompatibility In Discovery And Formulation Development
3/7/2024
We analyze drug-excipient incompatibility using a microcalorimeter system equipped with a multi-sample cell capable of simultaneously measuring highly sensitive heat flow data from up to three samples.
-
Selecting Container Closure Systems With Confidence: Lyophilization
3/7/2024
Experts take you through the entire selection process for primary packaging components for lyophilization and provide aspects to consider for all relevant attributes.
-
Advanced Fluid & Cold Chain Management For Bulk Drug Substances
3/7/2024
Achieve process excellence in commercial GMP handling of up to 500L of bulk drug substances or more per batch with flexible and secure products to improve the efficiency, scalability, and safety.
-
Producer Cell Line To Elevate Your AAV Production To The Next Level
3/6/2024
Discover a true producer cell line where Rep, Helper, Cap, and the gene of interest are stably integrated into the host cell's genome, requiring only a single induction step to initiate AAV production.
-
Exosome Isolation By TFF And Size Exclusion Chromatography
3/6/2024
Here, we demonstrate a scalable workflow for the isolation of exosomes that combines tangential flow filtration for the concentration of exosomes followed by gentle size exclusion chromatography.
-
A Scalable Single-Use Two-Step pDNA Purification Process
3/6/2024
Evaluate the performance of a single-use two-step plasmid purification process, and see how it compares to the existing three-step purification method.
-
A Stable Cell Line For Inducible AAV Production
3/6/2024
Delivering on the promise of AAV-based gene therapies beyond rare diseases will require large quantities of high-quality AAV, produced in a robust manner.
-
Lentiviral Vector CDMO Solutions
3/6/2024
Learn how our expertise in high-yield suspension cell lines, robust lentiviral vector production, and extensive quality control measures can expedite your innovative lentiviral vector programs.
-
Novel Engineered Plasmids, Optimized HEK293 Cell Line For AAV Productivity
3/5/2024
Lonza has further improved its platform process with the creation of engineered plasmids that afford significantly higher titers and productivity levels compared to standard systems.
-
Meet An Optimized Suspension-Based Platform Technology
3/5/2024
The ready-to-use, suspension-based Xcite® Lenti Platform Technology for transient transfection of LVVs eliminates that need to transition from small-scale adherent processes.